The Importance of Exercise in Patients with Diabetes

Boule NG, Haddad E, Kenny GP. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-27.

Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 3: CD002968, 2006.

Zinman B, Zuniga-Guajardo S, Kelly D. Comparison of the acute and long-term effects of exercise on glucose control in type-1 diabetes. Diabetes Care 1984; 7: 515-9.

Ramalho AC, De Lourdes Lima M, Nunes F. The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus. Diabetes Res Clin Pract 2006; 72: 271-6.

Mayer-Davis EJ, D’Aostino R, Kater AJ. Intensity and amount of physical activity in relation to insulin sensitivity. The Insulin Resistance Atherosclerosis Study. JAMA 1998; 279: 669-74.

Wei M, Gibbons LW, Mitchell TL. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 1999; 130: 89-96.

Eriksson KF, Linndgarde F. Prevention of type 2 (noninsulin-dependent) diabetes mellitus by diet and physical exercise; the 6-year Malmo feasibility study. Diabetologia 1991; 34: 891-8.

Pan XR, Li GW, Hu YH. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-44.

Tuomilehto J, Lindstrom J, Eriksson JG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.

Diabetes Prevention Research Group: Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med 2002; 346: 393-403.

American Diabetes Association. Standard of medical care in diabetes 2007. Diabetes Care 2007; 30: S1-S33.

DeFronzo RA, Jacot E, Jequier E. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.

Diabetes 1981; 30: 1000-7.

Grillo S, Gremeaux T, Le Marchand-Brustel Y. Potential role of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in insulin-stimulated glucose transporter 4 translocation in adipocytes. FEBS Lett 1999; 461: 277-9.

Wick KL, Liu F. A new molecular target of insulin action: regulating the pivotal PDK1. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 209-21.

Hill MM, Clark SF, Tucker DF. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol 1999; 19: 7771-81.

Cho H, Mu J, Kim JK. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292: 1728-31.

Farese RV, Sajan MP, Standaert ML. Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 2005; 33: 350-3.

Kim YB, Kotani K, Ciaraldi TP. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal mus-cle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 2003; 52: 1935-42.

Zeigerer A, McBrayer MK, McGraw TE. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004; 15: 4406-15.

Caro JF. Clinical review 26: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991; 73: 691-5.

DeFronzo RA, Sherwin RS, Kraemer N. Effect of physical training on insulin action in obesity. Diabetes 1987; 36: 1379-85.

Zierath JR, Handberg A, Tally M. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 1996; 39: 306-13.

Garvey WT, Maianu L, Zhu JH. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998; 101: 2377-86.

Caro JF, Sinha MK, Raju SM. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 1987; 79: 1330-7.

Goodyear LJ, Giorgino F, Sherman LA. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195-204.

Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action in skeletal muscle from patients with NIDDM. Mol Cell Biochem 1998; 182: 153-60.

Bjornholm M, Kawano Y, Lehtihet M. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 1997; 46: 524-7.

Cusi K, Maezono K, Osman A. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-20.

Mandarino LJ, Consoli A, Jain A. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 1996; 270: E463-E470.

Johnson AB, Argyraki M, Thow JC. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity. Metabolism 1991; 40: 252-60.

Damsbo P, Vaag A, Hother-Nielsen O. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 239-45.

Kim YB, Nikoulina SE, Ciaraldi TP. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999; 104: 733-41.

Karlsson HK, Zierath JR, Kane S. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 2005; 54: 1692-7.

Boden G, Lebed B, Schatz M. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50: 1612-7.

Perseghin G, Scifo P, De Cobelli F. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48: 1600-6.

Kim JK, Kim YJ, Fillmore JJ. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108: 437-46.

Itani SI, Zhou Q, Pories WJ. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000; 49: 1353-8.

Schmitz-Peiffer C, Browne CL, Oakes ND. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46: 169-78.

Goodyear LJ, Giorgino F, Balon TW. Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am J Physiol 1995; 268: E987-995.

Richter EA, Mikines KJ, Galbo H. Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 1989; 66: 876-85.

Wojtaszewski JF, Hansen BF, Kiens B. Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 1997; 46: 1775-1781.

Lee AD, Hansen PA, Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 1995; 361: 51-4.

Lund S, Holman GD, Schmitz O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A 1995; 92: 5817-21.

Yeh JI, Gulve EA, Rameh L. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 1995; 270: 2107-11.

Wojtaszewski JF, Higaki Y, Hirshman MF. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 1999; 104: 1257-64.

Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 1997; 246: 259-73.

Kemp BE, Mitchelhill KI, Stapleton D. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999; 24: 22-5.

Hayashi T, Hirshman MF, Fujii N. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000; 49: 527-31.

Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001; 23: 1112-9.

Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, Seifert MM, et al. AMP-activated protein kinase alpha 2 activity is not essential for contraction-and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 2005, 280: 39033-41.

Winder WW. Energy-sensing and signaling by AMPactivated protein kinase in skeletal muscle. J Appl Physiol 2001; 91: 1017-28.

Musi N, Hayashi T, Fujii N et al: AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 2001; 280: E677-E684.

Hayashi T, Hirshman MF, Kurth EJ. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47: 1369-73.

Bergeron R, Russell RR, 3rd, Young LH. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 1999; 276: E938-E944.

Richter EA, Nielsen JN, Jørgensen SB. Signalling to glucose transport in skeletal muscle during exercise. Acta Physiol Scand 2003; 178: 329-35.

Hughes VA, Fiatarone MA, Fielding RA. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993; 264: E855-E862.

Luciano E, Carneiro EM, Carvalho CR. Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3- kinase/Akt-1 pathway. Eur J Endocrinol 2002; 147: 149-57.

Mikines KJ, Farrell PA, Sonne B. Postexercise doseresponse relationship between plasma glucose and insulin secretion. J Appl Physiol 1988; 64: 988-99.

Richter EA, Garetto LP, Goodman MN. Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest 1982; 69: 785-93.

Wojtaszewski JF, Hansen BF, Gade, Kiens B, Markuns JF, Goodyear LJ, et al. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 2000; 49: 325-31.

Zhou Q, Dohm GL. Treadmill running increases phosphatidylinostol 3-kinase activity in rat skeletal muscle. Biochem Biophys Res Commun 1997; 236: 647-50.

Howlett KF, Sakamoto K, Hirshman MF. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. Diabetes 2002; 51: 479-83.

Howlett KF, Sakamoto K, Yu H. Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise. Metabolism 2006; 55: 1046-52.

Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 2004; 53: 1233-42.

Houmard JA, Shaw CD, Hickey MS. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am J Physiol 1999; 277: E1055- E1060.

Daugaard JR, Nielsen JN, Kristiansen S. Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes 2000; 49: 1092-5.

Stallknecht B, Larsen JJ, Mikines KJ. Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue. Am J Physiol Endocrinol Metab 2000; 279: E376-E385.

Short KR, Vittone JL, Bigelow ML. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52: 1888-96.

Anonymous. ADA/ACSM; diabetes mellitus and exercise. Joint position paper. Med Sci Sports Exerc 1997; 29: 1-6.